Provectus Biopharmaceuticals, Inc. (OTCMKTS:PVCT – Get Free Report) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 10,600 shares, a decrease of 85.7% from the February 29th total of 74,000 shares. Based on an average trading volume of 1,520,000 shares, the days-to-cover ratio is currently 0.0 days.
Provectus Biopharmaceuticals Stock Down 8.5 %
OTCMKTS PVCT traded down $0.02 on Thursday, hitting $0.18. 236,436 shares of the company were exchanged, compared to its average volume of 313,251. Provectus Biopharmaceuticals has a 12 month low of $0.06 and a 12 month high of $0.22. The stock has a fifty day moving average of $0.15 and a 200-day moving average of $0.12.
Provectus Biopharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Provectus Biopharmaceuticals
- How to invest in marijuana stocks in 7 steps
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Options Trading – Understanding Strike Price
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What is the Nikkei 225 index?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Provectus Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provectus Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.